Takeda Pharmaceuticals India Private Limited - Company Profile

It is a pharma foreign private limited company based in Bhiwandi, Maharashtra, India, established in 2011.

2011 Bhiwandi, Maharashtra, India Amalgamated

Last Updated: July 26, 2025

About Takeda Pharmaceuticals India Private Limited

Takeda Pharmaceuticals India Private Limited, a amalgamated foreign private limited company, was established on 01 February 2011 in Bhiwandi, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24239MH2011FTC212891. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹15.00 Cr and a paid-up capital of ₹4.99 Cr.

Formerly known as Takeda Medicines India Private Limited. It upholds a compliant status. Employing 1 professional, Its leadership includes Anoop Kishore Kamat (Director), Rajesh Eric Dmellokamath (Director), Gopal Agrawal (Director). Past directors included Vineet Singhal, Toshikazu Ban, Anoop Kishore Kamat. Its latest AGM occurred on 09 September 2022, with the balance sheet filed on 31 March 2022. It is based at Bld. B-4, Vadapa Village, Citylink Warehousing Complex Mumbai Nash, Ik Highway, Bhiwandi, Maharashtra, 421302.

Company Details

CIN/LLPIN
U24239MH2011FTC212891
Registration Number
212891
Incorporation Date
01 February 2011
Authorized Capital
₹15.00 Cr
Paid-Up Capital
₹4.99 Cr
ROC Code
Roc Mumbai
Listing Status
Unlisted
Company Status
Amalgamated

Key Metrics

Authorised Capital ₹ 15.00 Cr as on 26-07-2025
Paid Up Capital ₹ 4.99 Cr as on 26-07-2025
Company Age 15 Year, 1 Day
Last Filing with ROC 31 Mar 2022
Revenue Growth **** -1.99% (FY 2022)
Profit Growth **** -43.61% (FY 2022)
Ebitda **** 630.51% (FY 2022)
Net Worth 3.26% (FY 2022)
Total Assets -23.39% (FY 2022)

Comprehensive Company Insights

Explore comprehensive insights into Takeda Pharmaceuticals India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Takeda Pharmaceuticals India Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Anoop Kishore Kamat	Director	23 Apr 2021	Current
Rajesh Eric Dmellokamath	Director	31 Jul 2021	Current
Gopal Agrawal	Director	02 Mar 2020	Current
Serina Magner Fischer	Director	17 Mar 2022	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	30 Sep 2019	Past
Pramod Abcsdd	Director	05 Apr 2012	Past
Pramod Abcsdd	Additional Director	30 Sep 2021	Past
Pramod Abcsdd	Additional Director	30 Sep 2021	Past
Pramod Abcsdd	Director	20 Aug 2019	Past
Pramod Abcsdd	Director	29 May 2014	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Takeda Pharmaceuticals India.

Takeda Pharmaceuticals India Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 1.99% decrease. The company also saw a substantial fall in profitability, with a 43.61% decrease in profit. The company's net worth moved up by a moderate rise of 3.26%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-1.99%

*******

Revenue from Operations

*******

-0.74%

*******

Total Assets

*******

-23.39%

*******

Profit or Loss

*******

-43.61%

*******

Net Worth

*******

3.26%

*******

EBITDA

*******

630.51%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Takeda Pharmaceuticals India?

In 2021, Takeda Pharmaceuticals India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Takeda Pharmaceuticals India?

Takeda Pharmaceuticals India has a workforce of 1 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Takeda Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Takeda Pharmaceuticals India's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Takeda Pharmaceuticals India

Recent Activity within the Organization

Annual General Meeting

The activity Takeda Pharmaceuticals India Private Limited last Annual general meeting of members was held on 09 Sep 2022 as per latest MCA records. was completed.
09 Sep 2022
Balance Sheet

The activity Takeda Pharmaceuticals India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Mumbai. was completed.
31 Mar 2022
Director Appointment

The activity Serina Magner Fischer was appointed as a Director was appointed as a Director on 17 Mar 2022 & has been associated with this company since 3 years 10 months . was completed.
17 Mar 2022
Director Appointment

The activity Rajesh Eric Dmellokamath was appointed as a Director was appointed as a Director on 31 Jul 2021 & has been associated with this company since 4 years 6 months . was completed.
31 Jul 2021
Director Appointment

Progress on Anoop Kishore Kamat was appointed as a Director was appointed as a Director on 23 Apr 2021 & has been associated with this company since 4 years 9 months . was documented.
23 Apr 2021
Director Appointment

Gopal Agrawal was appointed as a Director was appointed as a Director on 02 Mar 2020 & has been associated with this company since 5 years 11 months . was recorded as a recent event.
02 Mar 2020

Explore recent activity and updates - View Recent Activity